MPTP selectively destroys dopaminergic neurons in the substantia nigra, producing a pattern of damage that closely mirrors Parkinson pathology
Refrigerate at 2-8C and use within 28 days
Medical history and medication review to flag any interactions or contraindications before prescribing Goal-specific protocol selection based on injury location, duration, and severity rather than a one-size-fits-all 500 mcg recommendation Written reconstitution and injection instructions with the exact mL and unit markings for the patients specific vial and prescribed dose Injection training for self-administration patients, either in-clinic or via telehealth video walkthrough Week-four check-in to assess response, adjust dose or frequency if needed, and confirm the patient is completing the cycle correctly Pharmacy-grade 503A product with verified purity, sterility, and potency from an FDA-registered compounding pharmacy For patients who have never injected a peptide before, we also review the BPC-157 benefits and mechanism in detail before starting the protocol so the patient understands what the peptide does, what to expect during the cycle, and what results realistically look like at four, eight, and twelve weeks
The tissue surrounding the injection point, which maintains a tightly regulated pH environment, responds to this disruption with the brief inflammatory signals that produce the stinging or burning sensation
Core Mechanisms Recap: NNMT Inhibition: Prevents NAD depletion, supporting energy production and metabolic flexibility
Its also used off-label for treatment-resistant depression and narcolepsy
